| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 08/28/2013 | CN103269720A Growth hormone conjugates |
| 08/28/2013 | CN103269718A Pharmaceutical formulation comprising a biopharmaceutical drug |
| 08/28/2013 | CN103269717A Gas-filled microvesicles for use as vaccine |
| 08/28/2013 | CN103269696A Felbinac-containing external patch |
| 08/28/2013 | CN103269690A Sustained-release polymeric microparticles containing poorly water-oluble drug and method for preparing the same |
| 08/28/2013 | CN103269689A Microparticles containing physiologically active peptide, method for preparing the same, and pharmaceutical composition comprising the same |
| 08/28/2013 | CN103269688A Tamper resistant dosage form comprising inorganic salt |
| 08/28/2013 | CN103269673A Fluid compositions comprising a structuring agent |
| 08/28/2013 | CN103265651A Preparation method of cyclodextrin cholesterylamide |
| 08/28/2013 | CN103265617A Preparation method with lauroyl aminoacyl proline methyl ester serving as novel chemical penetration enhancer and application |
| 08/28/2013 | CN103263688A Gelatin composition, and preparation method and application thereof |
| 08/28/2013 | CN103263675A Poly (epsilon-caprolactone) supported anti-tumor prodrug and preparation method thereof |
| 08/28/2013 | CN103263674A Tumor targeting material with tumor penetrating property, preparation method and applications thereof |
| 08/28/2013 | CN103263673A Polysaccharide-gold-nanoparticle supermolecule assembled body as well as preparation method and application thereof |
| 08/28/2013 | CN103263672A Preparation method and application of nanometer particles of taxane drugs |
| 08/28/2013 | CN103263671A Preparation and application of anti-tumor activator nanostructure lipid carrier |
| 08/28/2013 | CN103263670A Diazepam nasal delivery preparation and preparation method thereof |
| 08/28/2013 | CN103263656A Preparation method of external medicine film for treating uratoma |
| 08/28/2013 | CN103263651A Fresh ginger essential oil and mixed cyclodextrin inclusion compound and preparation method thereof |
| 08/28/2013 | CN103263476A Composite bacteriostatic agent for reducing irritation |
| 08/28/2013 | CN103263443A Bifidobacterium for dust mite allergy |
| 08/28/2013 | CN103263438A Smokeless moxa cone and preparation method thereof |
| 08/28/2013 | CN103263437A Tree-type high-molecular polyamide-amine wrapped platinum nanometer particles, its preparation method and applications |
| 08/28/2013 | CN103263436A Disodium adenosine triphosphate and magnesium chloride composition for injection, and freeze-dried powder injection and preparation method thereof |
| 08/28/2013 | CN103263413A Ketorolac implant and preparation method thereof |
| 08/28/2013 | CN103263404A Composite anaesthetic |
| 08/28/2013 | CN103263401A Pinenut oil pinolenic acid microcapsule and preparation method thereof |
| 08/28/2013 | CN103263400A Chlortetracycline microcapsule preparation and preparation method thereof |
| 08/28/2013 | CN103263399A Cefradine capsules and preparation method thereof |
| 08/28/2013 | CN103263398A Cefdinir composition capsule and preparation method thereof |
| 08/28/2013 | CN103263397A Lvermectin sustained-release dropping pill and preparation method thereof |
| 08/28/2013 | CN103263396A Meloxicam dispersible tablets and preparation method thereof |
| 08/28/2013 | CN103263395A Telmisartan tablet preparation and preparation method thereof |
| 08/28/2013 | CN103263394A Cetirizine hydrochloride tablet and related substance quality control method thereof |
| 08/28/2013 | CN103263393A Ardipusilloside I slow-release implant tablets and preparation method thereof |
| 08/28/2013 | CN103263392A Amoitone derivative long-circulation nanometer lipid carrier and preparation method thereof |
| 08/28/2013 | CN103263391A Doxycycline hydrochloride dry suspension and preparation method thereof |
| 08/28/2013 | CN103263390A Sorafenib nano particle and application thereof |
| 08/28/2013 | CN103263389A Cefoxitin sodium freeze-dried powder injection for injection and preparation method thereof |
| 08/28/2013 | CN103263388A Folic acid modified norcantharidin stealth niosome and preparation method thereof |
| 08/28/2013 | CN103263385A Celecoxib long-acting nano injection and preparation method thereof |
| 08/28/2013 | CN103263384A Edaravone composition injection and preparation method thereof |
| 08/28/2013 | CN103263381A Fiber type controllable drug sustained release system and preparation method thereof |
| 08/28/2013 | CN102727904B Heat resisting protective agent of bivalent live vaccine against highly pathogenic porcine reproductive and respiratory syndrome-pseudorabies and preparation method thereof |
| 08/28/2013 | CN102727903B Heatproof lyophilized protective agent for live vaccine JXA1-R strain for highly pathogenic porcine reproductive and respiratory syndrome and method for preparing the same |
| 08/28/2013 | CN102697910B Chinese medicinal extract dripping pill for treating diabetes and hyperlipidemia |
| 08/28/2013 | CN102697846B Yufengningxin coated dripping pill and preparation method thereof |
| 08/28/2013 | CN102631327B Enteric coated omeprazole pellet and preparation method thereof |
| 08/28/2013 | CN102631317B Povidone-iodine oral liquid and method for producing same |
| 08/28/2013 | CN102604083B Polymer modified lipid material and application thereof |
| 08/28/2013 | CN102600476B Preparation method and application of drug-carrying keratin film |
| 08/28/2013 | CN102584981B Mutant of interferon alpha and polyethylene glycol derivatives of mutant |
| 08/28/2013 | CN102579860B Child medicament extract composition and preparation method and application thereof |
| 08/28/2013 | CN102558337B Interferon alpha mutant and polyethylene glycol derivative thereof |
| 08/28/2013 | CN102492093B Preparation method and application of ultra-porous hydrogel containing natural plant polysaccharide |
| 08/28/2013 | CN102470133B Quinoline derivative-containing pharmaceutical composition |
| 08/28/2013 | CN102470123B Pharmaceutical composition containing dopamine receptor agonist |
| 08/28/2013 | CN102406626B Pramipexole hydrochloride slow release tablet and preparation method thereof |
| 08/28/2013 | CN102397535B Insulin crystal microsphere, insulin crystal microsphere suspension, and preparation method thereof |
| 08/28/2013 | CN102379850B Targeted administration liposome passing through mucus barriers of human bodies |
| 08/28/2013 | CN102349889B Composition containing dronedarone |
| 08/28/2013 | CN102302477B Cinobufagin dry power inhaler and preparation method and application thereof |
| 08/28/2013 | CN102274192B Carboxymethyl chitosan medicament-carrying microspheres and preparation method thereof |
| 08/28/2013 | CN102266420B Method for preparing heartleaf houttuynia herb injection |
| 08/28/2013 | CN102266305B Bifonazole vagina effervescent tablet and preparation method thereof |
| 08/28/2013 | CN102093403B Azobenzene group-containing complex lipid and intermediate, preparation method and application thereof |
| 08/28/2013 | CN102065696B Versatile disinfectant |
| 08/28/2013 | CN101919804B Application of solid dispersion to preparation of veterinary drugs |
| 08/28/2013 | CN101918455B Hydroxyalkyl starch derivatives and process for their preparation |
| 08/28/2013 | CN101848734B Labelled IIGF binding peptides for imaging |
| 08/28/2013 | CN101801520B Process for producing fine particles and the fine particles |
| 08/28/2013 | CN101732290B Stable solid formulation of egualen sodium |
| 08/28/2013 | CN101273977B Preparation technique of tryptanthrin preparations and uses thereof |
| 08/28/2013 | CN101194017B Conjugate comprising P21 protein for the treatment of cancer |
| 08/27/2013 | US8519102 Polymer Factor VIII moiety conjugates |
| 08/27/2013 | US8519098 Composition of a polypeptide and an amphiphilic compound in an ionic complex and the use thereof |
| 08/27/2013 | US8518981 Liquid pharmaceutical formulations of palonosetron |
| 08/27/2013 | US8518893 Medical compositions containing ghrelin |
| 08/27/2013 | US8518451 Thyroid hormone analogs and methods of use |
| 08/27/2013 | US8518442 Prolonged release bioadhesive therapeutic systems |
| 08/27/2013 | US8518435 Homeopathic formulation consisting of Bryonia alba and Pulsatilla spp |
| 08/27/2013 | US8518430 Dry mouldable drug formulation |
| 08/27/2013 | US8518421 Flashmelt oral dosage formulation |
| 08/27/2013 | US8518419 Method of treating diabetes |
| 08/27/2013 | US8518388 Cyclodextrin-based polymers for therapeutics delivery |
| 08/27/2013 | US8518362 Stabilization and ionic triggering of nitric oxide release |
| 08/27/2013 | CA2678754C Process for the preparation and purification of thiol-containing maytansinoids |
| 08/27/2013 | CA2615053C Pharmaceutical formulations of endo-n-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1-methyl-1h-indazole-3-carboxamide hydrochloride |
| 08/27/2013 | CA2584017C Aqueous ophthalmic suspension of crystalline rebamipide |
| 08/27/2013 | CA2521403C Macromolecules auto-assembled and photopolymerised around carbon nanotubes a method for production and application thereof |
| 08/27/2013 | CA2516163C High viscosity xanthan polymer preparations |
| 08/27/2013 | CA2505836C Topical brimonidine tartrate formulations that lack chlorine dioxide |
| 08/27/2013 | CA2403425C Multivalent antibodies and uses therefor |
| 08/22/2013 | WO2013123523A1 Uses of porous nanostructure in delivery |
| 08/22/2013 | WO2013123491A1 Self-regulated peptide hydrogel for insulin delivery |
| 08/22/2013 | WO2013123487A1 Alkalized acacia gum adhesive for oral adhering discs |
| 08/22/2013 | WO2013123466A1 Dietary and nutritional compositions and methods of use |
| 08/22/2013 | WO2013123426A1 Formulations and methods for the treatment or prophylaxis of pre-mci and/or pre-alzheimer's conditions |
| 08/22/2013 | WO2013123282A1 Xenoantigen-displaying anti-cancer vaccines and method of making |
| 08/22/2013 | WO2013122801A1 Ophthalmic pharmaceutical compositions and methods of making and using same |